R&D
Ⅰ. We provide research of bulk pharmaceutical chemicals and apply for technical service
scientific innovative medicine |
consignable company |
|
preliminary stage |
After undertaking consigned research and development, to provide process route and related technological data Complete small experiment research |
Low research cost, do not pay until success, low risk |
medium stage |
Complete pilot scale production, provide kg level sample product |
Reliable technical support |
late phase |
Provide unique N-2 and N-3 intermediate |
Stable material supply |
II. We provide customized development service for new drugs and key intermediates, including, new route development, pilot scale and large scale production. We have complete production and experiment equipment and testing instrument, such as, LC-MS, GC-MS and so on. We are professional in multi-step synthesis of raw material and natural products. We are good at low-temperature, carbon- carbon bond, carbon-nitrogen bond reaction.
(1)Full synthesis of natural cephalotaxus fortune ester base (independent design of route, under application of patent)
(2)New type C hepatitis virus(HCV) inhibitor (Boceprevir,1(Sch 503034)) key intermediate preparation
(3)Full synthesis of Flumatinib, drug for leukemia
III. We provide optimizing service for production technique of fine chemicals to reduce cost and improve quality.
Custom Manufacturing
Tianjin Scipharmacn has an environment where you can fulfill your personal goals. At the same time, you’d be working for a company that’s making a difference in the lives of people around the world through innovative medicines and related health care products.
Tianjin Scipharmacn offer exciting and challenging careers within an energising environment where your ideas and skills are valued; where you are supported in developing to your full potential and where your individual contribution is respected, recognised and rewarded.
Welcome to join Tianjin Scipharmacn. We provide outstanding career opportunities for you.
Join us and make a difference.